ImpediMed Names Erik Anderson as New Chief Executive Officer Amid Business Expansion ImpediMed has appointed Erik Anderson as CEO following his successful tenure at Hologic. His focus will be on growth and expanding product adoption.

ImpediMed Names Erik Anderson as New Chief Executive Officer Amid Business Expansion #United_States #Carlsbad #ImpediMed #BCRL #Erik_Anderson

ImpediMed Welcomes Erik Anderson as New Board Director to Propel Medical Tech Growth ImpediMed, a leader in medical technologies, appoints Erik Anderson to its Board of Directors, enhancing its strategic direction and growth.

ImpediMed Welcomes Erik Anderson as New Board Director to Propel Medical Tech Growth #United_States #Carlsbad #ImpediMed #Medical_Technologies #Erik_Anderson

Enhancing Lymphedema Management Through Early Detection Strategies in Breast Cancer Patients ImpediMed emphasizes the significance of pre-treatment baseline screenings for breast cancer-related lymphedema, enhancing early detection and management for patients.

Enhancing Lymphedema Management Through Early Detection Strategies in Breast Cancer Patients #USA #Las_Vegas #Breast_Cancer #ImpediMed #Lymphedema

ImpediMed Secures $15M Growth Capital Funding #healthIT #ImpediMed
www.healthcareittoday.com/?p=2519225

ImpediMed Secures $15 Million to Advance Lymphedema Detection Technologies ImpediMed has announced a $15 million growth capital funding agreement to enhance its innovative lymphedema detection technology, SOZO.

ImpediMed Secures $15 Million to Advance Lymphedema Detection Technologies #United_States #Carlsbad,_California #ImpediMed #SOZO #Lymphedema

ImpediMed Honored with Frost & Sullivan's 2025 Technology Innovation Leadership Award ImpediMed has earned the prestigious Frost & Sullivan 2025 Technology Innovation Leadership Award, showcasing its advanced SOZO® Digital Health Platform for monitoring health.

ImpediMed Honored with Frost & Sullivan's 2025 Technology Innovation Leadership Award #United_States #Carlsbad #ImpediMed #SOZO® #BCRL